← Open Payments lookup

SYED ANWAR: Open Payments

NPI 1053314401 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$262 in 12 payments from 10 companies in 2025. Trend: 2023 $283 · 2024 $178 · 2025 $262

Food & beverage: $262
CompanyPaymentsAmount
Neurelis, Inc.1$39
AstraZeneca Pharmaceuticals LP2$35
GlaxoSmithKline, LLC.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$31
Teva Pharmaceuticals USA, Inc.1$26
Xeris Pharmaceuticals, Inc.1$23
Lundbeck LLC1$22
PFIZER INC.1$21
SANOFI-AVENTIS U.S. LLC1$16
Lilly USA, LLC1$16

Products named: VALTOCO, SHINGRIX, CAPLYTA, UZEDY, GVOKE HYPOPEN, REXULTI, AIRSUPRA, ELIQUIS.

Industry payments across TX — which companies pay providers there.